Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

Liège, Belgium, May 30, 2017 – Imcyse, who develop active specific therapies for the treatment and prevention of severe chronic…